Recent studies have identified the presence of SARM1 variants with constitutively hyperactive NADase activity in patients with ALS and other motor nerve disorders, demonstrating the role of SARM1 as a candidate genetic risk factor for these diseases (Bloom and others 2022; Gilley and others 2021). The gene discussed is SARM1; the disease is amyotrophic lateral sclerosis.